Medicare Enrolled

Dr. Robert Reagle, DO

Pulmonary Disease · Clarkston, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5701 BOW POINTE DR STE 365, Clarkston, MI 48346
2489229283
In practice since 2005 (20 years)
NPI: 1619959509 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reagle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reagle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reagle

Dr. Robert Reagle is a pulmonary disease specialist in Clarkston, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reagle performed 471 Medicare services across 372 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reagle received a total of $13,831 from 48 pharmaceutical and/or device companies across 656 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reagle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 471 Medicare services $13,831 industry payments

Medicare Practice Summary

Medicare Utilization ↗
471
Medicare services
Bottom 44% in MI for pulmonary disease
372
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
228 $61 $85
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
181 $84 $120
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $119 $185
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
15 $39 $100
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
15 $40 $100
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $84 $165
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,831
Total received (2018-2024)
Avg $1,976/year across 7 years
Top 9% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
656
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,831 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$577
2023
$2,822
2022
$2,324
2021
$2,373
2020
$1,298
2019
$2,557
2018
$1,879

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
HARMONY BIOSCIENCES LLC
$142
Mylan Specialty L.P.
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Actelion Pharmaceuticals US, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$38
GENZYME CORPORATION
$36
Takeda Pharmaceuticals U.S.A., Inc.
$34
Inspire Medical Systems, Inc.
$33
AstraZeneca Pharmaceuticals LP
$31
Itamar Medical Inc
$25
Avadel CNS Pharmaceuticals, LLC
$24
United Therapeutics Corporation
$24
Regeneron Healthcare Solutions, Inc.
$22
ANI Pharmaceuticals, Inc.
$16
Electromed, Inc.
$15
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,413
GlaxoSmithKline, LLC.
$2,221
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,497
JAZZ PHARMACEUTICALS INC.
$1,455
Harmony Biosciences LLC
$629
Mylan Specialty L.P.
$550
Regeneron Healthcare Solutions, Inc.
$444
Takeda Pharmaceuticals U.S.A., Inc.
$433
Jazz Pharmaceuticals Inc.
$405
Grifols USA, LLC
$399
Sunovion Pharmaceuticals Inc.
$348
Philips Electronics North America Corporation
$294
Alexion Pharmaceuticals, Inc.
$255
HARMONY BIOSCIENCES LLC
$255
GENZYME CORPORATION
$229
Mallinckrodt Enterprises LLC
$184
United Therapeutics Corporation
$163
Electromed, Inc.
$158
Genentech USA, Inc.
$146
Shire North American Group Inc
$123
Teva Pharmaceuticals USA, Inc.
$114
Pulmonx Corporation
$99
Circassia Pharmaceuticals Inc
$98
Actelion Pharmaceuticals US, Inc.
$83
Mallinckrodt LLC
$80
ANI Pharmaceuticals, Inc.
$71
Merck Sharp & Dohme LLC
$70
Mallinckrodt Hospital Products Inc.
$69
Insmed, Inc.
$60
Inspire Medical Systems, Inc.
$57
Amgen Inc.
$53
Advanced Respiratory, Inc
$45
Axsome Therapeutics, Inc.
$33
ARBOR PHARMACEUTICALS, INC.
$32
Resmed Corp
$28
ABBVIE INC.
$25
Itamar Medical Inc
$25
Avadel CNS Pharmaceuticals, LLC
$24
Cumberland Pharmaceuticals, Inc.
$20
Paratek Pharmaceuticals, Inc.
$19
Novartis Pharmaceuticals Corporation
$19
SANOFI-AVENTIS U.S. LLC
$19
La Jolla Pharmaceutical Company
$18
Covis Pharma GmBH
$17
Arbor Pharmaceuticals, Inc.
$15
PFIZER INC.
$14
E.R. Squibb & Sons, L.L.C.
$14
Gilead Sciences, Inc.
$13
Top 3 companies account for 44.3% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · AirDuo Digihaler · Andexxa · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · CUTAQUIG · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Disposable Vest · ELIQUIS · Esbriet · FARXIGA · FASENRA · GIAPREZA · GLASSIA · Horizant · INSPIRE · LONHALA MAGNAIR · LUMRYZ · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Respiratoriy Care Undiv · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · ULTOMIRIS · UTIBRON · UTIBRON NEOHALER · Ultomiris · Utibron · VERQUVO · Vibativ · WAKIX · Wakix · WatchPATONE · Wellcentive Undiv · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for pulmonary disease in MI.

Looking for a pulmonary disease specialist in Clarkston?
Compare pulmonary diseases in the Clarkston area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
72
Per 100K population
5.7
County median income
$95,296
Nearest hospital
MCLAREN OAKLAND
9.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Reagle is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Reagle experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Reagle performed 228 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reagle receive payments from pharmaceutical companies?
Yes. Dr. Reagle received a total of $13,831 from 48 companies across 656 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reagle's costs compare to other pulmonary diseases in Clarkston?
Dr. Reagle's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reagle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →